Unique Fabricating (UFABQ) 10-Q 12 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	Apr. 29, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-37480
Entity Registrant Name	UNIQUE FABRICATING, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-1846791
Entity Address, Address Line One	800 Standard Parkway
Entity Address, City or Town	Auburn Hills
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48326
City Area Code	248
Local Phone Number	853-2333
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	UFAB
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,733,147
Entity Central Index Key	0001617669
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 752	$ 742
Accounts receivable, net of reserves of approximately $1.1 million and $1.3 million at March 31, 2022 and December 31, 2021, respectively	26,566	23,469
Inventory, net	13,477	13,770
Prepaid expenses and other current assets:
Prepaid expenses and other	3,099	3,270
Refundable taxes	4,342	3,738
Total current assets	48,236	44,989
Property, plant, and equipment, net	21,981	22,567
Goodwill	16,996	16,996
Intangible assets	4,700	5,161
Other assets
Operating leases	9,757	9,776
Investments, at cost	1,054	1,054
Deposits and other assets	775	755
Deferred tax asset	2,379	2,379
Total assets	105,878	103,677
Current liabilities:
Accounts payable	14,117	10,056
Current maturities of long-term debt	27,713	28,884
Income taxes payable	311	303
Revolver, current maturities	19,336	19,541
Accrued compensation	1,709	1,149
Other accrued liabilities	3,237	3,478
Total current liabilities	66,423	63,411
Long-term debt, net of current maturities	0	0
Other long-term liabilities:
Other liabilities	8,856	9,139
Total liabilities	75,279	72,550
Stockholders’ equity:
Common stock, $0.001 par value: 15,000,000 shares authorized and 11,733,147 and 11,733,147 issued and outstanding at March 31, 2022 and December 31, 2021, respectively	12	12
Additional paid-in-capital	50,390	50,349
Accumulated deficit	(19,803)	(19,234)
Total stockholders’ equity	30,599	31,127
Total liabilities and stockholders’ equity	$ 105,878	$ 103,677

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 1.1	$ 1.3
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	15,000,000	15,000,000
Common stock, shares issued (in shares)	11,733,147	11,733,147
Common stock, shares outstanding (in shares)	11,733,147	11,733,147

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net sales	$ 35,312	$ 34,798
Cost of sales	30,534	28,936
Gross profit	4,778	5,862
Selling, general, and administrative expenses	4,972	5,814
Operating income (loss)	(194)	48
Other income (expense):
Other, net	(59)	18
Interest expense	(481)	(693)
Other expense, net	(540)	(675)
Loss before income taxes	(734)	(627)
Income tax expense (benefit)	(165)	442
Net loss	$ (569)	$ (1,069)
Net loss per share:
Basic (in dollars per share)	$ (0.05)	$ (0.11)
Diluted (in dollars per share)	$ (0.05)	$ (0.11)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2020		9,779,147
Stockholders' equity, beginning balance at Dec. 31, 2020	$ 33,865	$ 10	$ 46,126	$ (12,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,069)			(1,069)
Stock option expense	27		27
Stockholders' equity, ending balance (in shares) at Mar. 31, 2021		9,779,147
Stockholders' equity, ending balance at Mar. 31, 2021	32,823	$ 10	46,153	(13,340)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021		11,733,147
Stockholders' equity, beginning balance at Dec. 31, 2021	31,127	$ 12	50,349	(19,234)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(569)			(569)
Stock option expense	41		41
Stockholders' equity, ending balance (in shares) at Mar. 31, 2022		11,733,147
Stockholders' equity, ending balance at Mar. 31, 2022	$ 30,599	$ 12	$ 50,390	$ (19,803)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (569)	$ (1,069)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,276	1,644
Amortization of debt issuance costs	56	45
Loss on sale of assets	0	14
Bad debt adjustment	(72)	(118)
Loss (gain) on derivative instrument	(380)	(185)
Stock option expense	41	27
Accrued in-kind interest on long term debt	39	0
Changes in operating assets and liabilities that provided (used) cash:
Accounts receivable	(3,025)	(3,142)
Inventory	293	(1,611)
Prepaid expenses and other assets	(452)	1,317
Accounts payable	4,107	3,485
Other assets and liabilities, net	444	(317)
Net cash provided by operating activities	1,758	90
Cash Flows from Investing Activities:
Capital expenditures	(229)	(1,530)
Proceeds from sale of property, plant, and equipment	0	65
Net cash used for investing activities	(229)	(1,465)
Cash Flows from Financing Activities:
Net change in bank overdraft	(46)	(922)
Payments on term loans and capital expenditure line	(1,228)	(1,007)
Payments on revolving credit facilities	(13,824)	(6,280)
Proceeds from revolving credit facilities	13,579	11,553
Net cash provided by (used for) financing activities	(1,519)	3,344
Cash and Cash Equivalents:
Net increase in cash and cash equivalents	10	1,969
Cash and cash equivalents at beginning of period	742	760
Cash and cash equivalents at end of period	752	2,729
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	774	815
Cash paid for income taxes	$ 112	$ 226

Nature of Business and Basis of

Nature of Business and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Nature of Business and Basis of Presentation	Nature of Business and Basis of Presentation Nature of Business Unique Fabricating, Inc. (the “Company”) engineers and manufactures components for customers in the transportation, appliance, medical, and consumer / off-road markets. The Company’s solutions are comprised of multi-material foam, rubber, and plastic components, and utilized in noise, vibration and harshness (“NVH”) management, acoustical management, water and air sealing, decorative and other functional applications. The Company leverages proprietary manufacturing processes, including die cutting, thermoforming, compression molding, fusion molding, and reaction injection molding to manufacture a wide range of products, including air management products, heating, ventilating, and air conditioning (“HVAC”), seals, fender stuffers, air ducts, acoustical insulation, door water shields, gas tank pads, light gaskets, topper pads, mirror gaskets, glove box liners, personal protection equipment, and packaging. The Company operates as one reportable segment and is headquartered in Auburn Hills, Michigan. Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Going Concern The Company’s condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2020 and March 31, 2021, the Company was in violation of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). The Company entered into a forbearance agreement, dated April 9, 2021, which allowed the Company to be able to borrow on its revolving line of credit, subject to the terms and conditions to making a revolving credit advance, including availability, and the lenders agreed, subject to the terms of the forbearance agreement, as amended, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. As of September 30, 2021, the Company was also in violation of the required Minimum Consolidated EBITDA covenant (as amended by the Second Amendment to the Forbearance Agreement dated September 21, 2021). On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement with respect to the Amended and Restated Credit Agreement, as amended. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment included a new covenant that began on December 15, 2021, which is tested weekly on a rolling basis and requires that the Company’s actual cumulative total cash disbursements for the period being tested not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required Minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment to the Forbearance Agreement agreed to waive the Minimum Liquidity covenant violation. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement The defaults, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement, totaling $47.0 million, has been classified as current as of March 31, 2022. The Company does not have sufficient cash and cash equivalents on hand or available liquidity to repay such debt or meet its obligations as they become due through twelve months from date of issuance of these condensed consolidated financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, the Company is discussing with its bank lenders entering into an amendment and waiver to cure the covenant defaults. There is not any assurance that the lenders will waive such non compliance or agree to an amendment to the current provisions. Even if the lenders were to agree to waive the failures to comply as of December 31, 2020, March 31, 2021, and September 30, 2021, there cannot be any assurance that, at any future date at which compliance is measured, we will be able to comply with the covenants contained in the forbearance agreement, as amended, given the industry-wide and other challenges that we face, as described elsewhere herein, or that our lenders would waive a default if that were to occur. Furthermore, there can be no assurance that the Company will be able to enter into an amendment or waiver with the lenders or if it enters into an amendment, what the terms, restrictions, and covenants of the amendment will contain. These plans have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Concentration Risks The Company is exposed to significant concentration risks as follows: Customer and Credit — During the three months ended March 31, 2022 and March 31, 2021, the Company’s net sales were principally derived from customers engaged in the North American automotive industry. The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended March 31, 2022 2021 General Motors Company 9 % 7 % Yanfeng Automotive Interiors 10 % 7 % Stellantis N.V. 8 % 6 % Ford Motor Company 5 % 5 % Furthermore, the Company had additional sales to the customers listed in the above table indirectly through other customers. International Operations — The Company manufactures and sells products outside of the United States primarily in Mexico and Canada. Foreign operations are subject to various political, economic and other risks and uncertainties inherent in foreign countries. Among other risks, the Company’s operations may be subject to the risks of: restrictions on transfers of funds; export duties, quotas, and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; political conditions; and governmental regulations. The following table presents the percentage of the Company's total production in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 25 % 23 % Canada 9 % 10 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 26 % 24 % Canada 9 % 10 % Labor Markets — At March 31, 2022, 49% of our employees were working in the United States, 48% were working in Mexico, and 3% were working in Canada. In the United States manufacturing facilities, 29% were covered under a collective bargaining agreement which expires in August 2022 while another 15% were covered under a separate collective bargaining agreement that expires in February 2023.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform (Topic 848). The amendments in this ASU clarify that certain option expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected.

Revenues

Revenues	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenues	Revenues The following table presents the Company's net sales disaggregated by major sales channel: Three Months Ended March 31, 2022 2021 (dollars in thousands) Net Sales Transportation $ 31,449 $ 31,244 Appliance 3,124 3,135 Other 739 419 Total $ 35,312 $ 34,798 General Recognition Policy Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances

Inventory

Inventory	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventory	Inventory Inventories consist of the following: March 31, 2022 December 31, 2021 (dollars in thousands) Raw materials $ 9,472 $ 9,242 Work in progress 1,195 990 Finished goods 2,810 3,538 Total inventory $ 13,477 $ 13,770 The Company periodically evaluates inventory for obsolescence, excess quantities, slow moving goods and other impairments of value and establishes reserves for any identified impairments. The allowance for obsolete inventory was $1.4 million at March 31, 2022 and $1.2 million at December 31, 2021. Included in inventory are assets located in Mexico with a carrying amount of $3.7 million at March 31, 2022 and $4.0 million at December 31, 2021, and assets located in Canada with a carrying amount of $1.2 million at March 31, 2022 and $1.1 million at December 31, 2021.

Property, Plant, and Equipment,

Property, Plant, and Equipment, Net	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment, Net	Property, Plant, and Equipment, Net Property, plant, and equipment, net consists of the following: March 31, 2022 December 31, 2021 Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 7,630 7,630 23 – 40 Shop equipment 26,108 26,049 7 – 10 Leasehold improvements 1,283 1,283 3 – 10 Office equipment 3,048 3,047 3 – 7 Mobile equipment 50 50 3 Construction in progress 1,724 1,554 Total cost 40,381 40,151 Less: Accumulated depreciation 18,400 17,584 Net property, plant, and equipment, net $ 21,981 $ 22,567 Depreciation expense was $0.8 million for the three months ended March 31, 2022, and $0.7 million for the three months ended March 31, 2021. Included in property, plant, and equipment, net are assets located in Mexico with a carrying amount of $3.5 million and $3.5 million at March 31, 2022 and December 31, 2021, respectively, and assets located in Canada with a carrying amount of $0.4 million and $0.4 million at March 31, 2022 and December 31, 2021, respectively.

Long-term Debt

Long-term Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-term Debt	Long-term Debt The Company’s long-term debt consists of the following: March 31, 2022 December 31, 2021 (dollars in thousands) US Term Loan, payable to lenders in quarterly installments of $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the US Term Loan is presented net of a debt discount of $113 thousand from costs paid to or on behalf of the lenders. $ 19,607 $ 20,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the CA Term Loan is presented net of a debt discount of $49 thousand from costs paid to or on behalf of the lenders. 7,082 7,437 Capital expenditure line payable to lenders in quarterly installments of 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. 1,024 1,064 Total debt excluding Revolver $ 27,713 $ 28,884 As of March 31, 2022 and December 31, 2021, the fair value of the Company’s debt approximates book value based on the variable terms. Credit Agreement On November 8, 2018, Unique Fabricating NA, Inc. (the “US Borrower”) and Unique-Intasco Canada, Inc. (the “CA Borrower” and together with US Borrower, the “Borrowers”) and Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and other lenders (collectively, the “Lenders”), entered into an Amended and Restated Credit Agreement (the “Credit Agreement”), which amended and restated the Original Credit Agreement entered into on April 29, 2016 (as amended, the “Original Credit Agreement”). The Credit Agreement is a five-year agreement and provided for borrowings up to an aggregate principal amount of $73.0 million. The Credit Agreement, which is a senior secured credit facility comprised of a revolving line of credit of up to $30.0 million (the “Revolver”) to the US Borrower, a $26.0 million principal amount term loan (the “US Term Loan”) to the US Borrower, a $12.0 million principal amount term loan (the “CA Term Loan”) to the CA Borrower, and a two-year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020 to the US Borrower (the “Capital Expenditure Line”). The Credit Agreement has a maturity date for all borrowings of November 7, 2023. The Credit Agreement, as amended, bears interest at the Company’s election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 3.25% per annum in the case of the Base Rate and 2.75% to 4.25% per annum in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds, measured quarterly, as increased by the Waiver and Fourth Amendment to the Credit Agreement. The Seventh Amendment to the Credit Agreement added a 1.0% LIBOR Floor and 2.0% Base Rate Floor. The First Amendment to the Forbearance Agreement increased the per annum interest rate from 4.25% to 4.50% for the duration of the Forbearance Period. Furthermore, the First Amendment imposes Payment in Kind (“PIK”) additional interest of 0.5% per annum on all outstanding debt subject to the Credit Agreement, which is payable on May 30, 2022, currently the termination date of the Forbearance Agreement, or earlier in the event of a Forbearance Termination event, as defined. As of March 31, 2022, $19.6 million was outstanding under the Revolver. This amount is gross of debt issuance costs which are further described in the next section. The Revolver had an effective interest rate of 5.50% percent per annum at March 31, 2022, and is secured by substantially all of the Company’s assets. At March 31, 2022, the maximum additional available borrowings under the Revolver was $5.2 million, which includes a reduction for a $0.1 million letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. The Company’s financial results for the six months ended December 31, 2020 and the nine months ended March 31, 2021 resulted in violations of one or more of the following financial covenants: (1) Maximum Total Leverage Ratio; (2) Minimum Debt Service Coverage Ratio; and (3) Minimum Consolidated EBITDA; as defined in the Company’s Credit Agreement. The Company entered into a Forbearance Agreement, providing a period commencing on April 9, 2021 and through and including June 15, 2021, during which the Company was able to borrow on its Revolver, subject to the terms and conditions to making a revolving credit advance, including availability, and the Lenders agreed, subject to the terms of the Forbearance Agreement, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. On June 14, 2021, the Company entered into the First Amendment to the Forbearance Agreement, which among other things, extended the forbearance period from June 15, 2021 to February 28, 2022 and waived the testing of the Maximum Total Leverage Ratio and Minimum Debt Service Coverage ratios for the duration of the Forbearance Period. The First Amendment also substituted Minimum Liquidity and Minimum Consolidated EBITDA requirements which would be tested monthly beginning with the month ending July 31, 2021. During the extended period, the Company was able to borrow under the revolving line of credit, subject to availability and satisfaction of certain other conditions. On September 21, 2021, the Company entered into the Second Amendment to Forbearance Agreement, which among other things, made changes to the calculations of financial covenants, contained revised requirements for Minimum Liquidity and Minimum Consolidated EBITDA, as defined, for the monthly periods through and including February 28, 2022, and revised the Revolving Credit Aggregate Commitment from $30 million to $27 million. On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement. As previously reported, the Company was in violation of the required Minimum Consolidated EBITDA Covenant (as amended by the Second Amendment to the Forbearance Agreement) as of September 30, 2021. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment includes a new covenant tested weekly on a rolling basis, beginning December 15, 2021, and required that the Company’s actual cumulative total cash disbursements for the period being tested to not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement, dated September 21, 2021. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment agreed to waive the minimum Liquidity covenant violation. The Company did have the required minimum liquidity by the conclusion of the first week of 2022. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement. Debt Issuance Costs Debt issuance costs represent legal, consulting, and other financial costs associated with debt financing and are reported netted against the related debt instrument. Amounts paid to or on behalf of lenders are presented as a debt discount and are also shown as a reduction of the associated debt instrument. Debt issuance costs on term debt are amortized using the straight line basis over the term of the related debt (which is immaterially different from the required effective interest method) while those related to revolving debt are amortized using a straight line basis over the term of the related debt. At March 31, 2022 and December 31, 2021, unamortized debt issuance costs were $0.2 million and $0.2 million, respectively, while amounts paid to or on behalf of lenders presented as unamortized debt discounts were $0.2 million and $0.2 million, respectively. Amortization expense of both debt issuance costs and debt discounts has been recognized as a component of interest expense in the amounts of $0.1 million for the three months ended March 31, 2022, and $0.1 million for the three months ended March 31, 2021. Covenant Compliance The Amended and Restated Credit agreement, as further amended and forbore by the Forbearance Agreement, as amended, contains the following financial covenants: Maximum Total Leverage Ratio The Total Leverage Ratio, as defined in the Credit Agreement, as amended, may not exceed (i) 3.75 to 1.00, with respect to the fiscal quarter ended as of September 30, 2020; (ii) 3.50 to 1.00, with respect to the fiscal quarter ended December 31, 2020; (iii) 3.25 to 1.00, with respect to the fiscal quarters ended March 31, 2021 and June 30, 2021; and (iv) 3.00 to 1.00, with respect to each fiscal quarter thereafter. For purposes of calculating the Total Leverage Ratio, “Consolidated EBITDA”, as defined, shall be determined (i) with respect to the fiscal quarter ended as of September 30, 2020, for the single fiscal quarter then ended, multiplied by 4,(ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, multiplied by 2, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, multiplied by 4/3, and (iv) with respect to each fiscal quarter thereafter, for the four fiscal quarters then ended. Also, for purposes of calculating the Total Leverage Ratio, the PPP Note is excluded from Total Debt for all periods until a determination of forgiveness is made. However, testing of the Total Leverage Ratio is suspended during the Forbearance Period. Minimum Debt Service Coverage Ratio The Debt Service Coverage Ratio may not be less than 1.20 to 1.00, to be measured, as of the end of each fiscal quarter. Notwithstanding anything to the contrary set forth in the definition of "Debt Service Coverage Ratio," such calculation shall be made (i) with respect to the fiscal quarter ended as of September 30 2020, for the single fiscal quarter then ended, (ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, and (iv) with respect to the last day of each fiscal quarter thereafter, for the four fiscal quarters then ended. However, testing of the Minimum Debt Service Coverage Ratio is suspended during the Forbearance Period. Projected Cash Disbursements The Third Amendment to the Forbearance Agreement establishes a financial covenant limiting the Company’s cash disbursements for the duration of the Forbearance Period. Commencing on December 15, 2021, the cumulative total cash disbursements may not exceed the Company’s projected total cash disbursements for the same cumulative period by more than 15%. Future Maturities The loan covenant defaults mentioned previously, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement has been classified as current as of March 31, 2022: Future Maturities (dollars in thousands) 2022 $ 47,426 Total 47,426 Discounts (162) Debt issuance costs (215) Total debt, net $ 47,049

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Interest Rate Swap The Company holds a derivative financial instrument, in the form of an interest rate swap, as required by its Credit Agreement, for the purpose of hedging certain identifiable transactions in order to mitigate risks relating to the variability of future earnings and cash flows caused by interest rate fluctuations. The Company has elected not to apply hedge accounting for financial reporting purposes. The interest rate swap is recognized in the accompanying condensed consolidated balance sheets at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized currently in net income as interest expense in the accompanying condensed consolidated statements of operations. Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into an interest rate swap that requires the Company to pay a fixed rate of 3.075% per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5.0 million, which increased by $0.4 million each quarter until June 28, 2019 when the notional amount increased to $17.5 million due to the interest rate swap from 2016 expiring. Since June 28, 2019, the notional amount then decreased each quarter by $0.2 million until September 30, 2020 when the notional amount increased to $17.5 million due to the interest rate swap from 2017 expiring. The notional amount then decreased each quarter by $0.4 million until December 31, 2021, then decreases each subsequent quarter by $0.6 million until it expires on November 8, 2023. At March 31, 2022, the fair value of all swaps was in a net liability position of $0.2 million and is included in other long term liabilities in the condensed consolidated balance sheets. At December 31, 2021, the fair value of the swap was $0.6 million. The Company paid $0.1 million in net monthly settlements with respect to the interest rate swaps for the three months ended March 31, 2022 and the three months ended March 31, 2021. Both the change in fair value and the net monthly settlements were included in interest expense in the condensed consolidated statements of operations.

Stock Incentive Plans

Stock Incentive Plans	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock Incentive Plans	Stock Incentive Plans 2013 Stock Incentive Plan The Company’s board of directors approved a stock incentive plan (the “Plan”) in 2013. The Plan permits the Company to grant 495,000 non statutory or incentive stock options to the employees, directors and consultants of the Company. 495,000 shares of unissued common stock are reserved for the Plan. The board of directors has the authority to determine the participants to whom stock options shall be awarded as well as any restrictions to be placed upon the awards. The exercise price cannot be less than the fair value of the underlying shares at the time the stock options are issued and the maximum length of an award is ten years. 2014 Omnibus Performance Award Plan In 2014, the board of directors and stockholders adopted the Unique Fabricating, Inc. 2014 Omnibus Performance Award Plan, or the 2014 Plan. The 2014 Plan provides for the grant of cash awards, stock options, stock appreciation rights, or SARs, shares of restricted stock and restricted stock units, or RSUs, performance shares and performance units. The 2014 Plan originally authorized the grant of awards relating to 250,000 shares of our common stock. In the event of any transaction that causes a change in capitalization, the compensation committee, such other committee administering the 2014 Plan or the board of directors will make such adjustments to the number of shares of common stock delivered, and the number and/or price of shares of common stock subject to outstanding awards granted under the 2014 Plan, as it deems appropriate and equitable to prevent dilution or enlargement of participants’ rights. An amendment approved in March of 2016 by our board of directors which was approved by our stockholders at our annual meeting of stockholders in June 2016, increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 450,000 shares of our common stock. In July 2020, an additional amendment was approved at our annual meeting of stockholders, which increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 700,000 shares of our common stock. The fair value of each of the option awards is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following tables. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options for adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant. A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2021 846,731 $ 4.00 7.6 $ — Granted — $ — 0 $ — Exercised — $ — 0 $ — Forfeited or expired 13,647 $ 4.51 0 $ — Outstanding at March 31, 2022 833,084 $ 4.00 7.4 $ — Vested and exercisable at March 31, 2022 390,129 $ 4.81 6.4 $ — ———————————— (1) The aggregate intrinsic value above is obtained by subtracting the exercise price from the estimated fair value of the underlying shares and multiplying this result by the related number of options outstanding and exercisable as of the period end date. There is no intrinsic value if the exercise price exceeds the fair value of the underlying shares. The estimated fair value of the shares is based on the closing price of the stock of $1.90 as of March 31, 2022 and $1.96 as of December 31, 2021. The Company recorded stock-based compensation expense of $41 thousand for the three months ended March 31, 2022, respectively, and $27 thousand for the three months ended March 31, 2021, respectively. Stock compensation expense is included in the condensed consolidated statements of operations, as a component of selling, general, and administrative expenses. The income tax (expense) benefit related to share based compensation expense was immaterial for all periods presented. As of March 31, 2022, there was $577 thousand of total unrecognized compensation cost related to non-vested stock option awards under the plans. That cost is expected to be recognized over a weighted average period of 3.6 years.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For interim tax reporting we estimate our annual effective tax rate and apply it to our year to date income before income taxes. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and the effect of changes in tax laws or rates, are reported in the interim period in which they occur, if applicable. Income tax benefit for the three months ended March 31, 2022, was $(0.2) million, compared to income tax expense of $0.4 million for the three months ended March 31, 2021. During the three months ended March 31, 2022, the effective tax rate was 22%. The differences between the effective tax rates and the statutory rate of 21% were primarily related to a mix of earnings in jurisdictions which have higher income tax rates than the U.S.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases The Company records a right-of-use (“ROU”) asset and lease liability for substantially all leases for which it is a lessee, in accordance with ASC 842. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company has no significant lease agreements in place for which the Company is a lessor. At inception of a contract, the Company considers all relevant facts and circumstances to assess whether or not the contract represents a lease by determining whether or not the contract conveys the right to control the use of an identified asset, either explicit or implicit, for a period of time in exchange for consideration. The Company leases certain industrial spaces, office space, land, and equipment. Some leases include one or more options to renew, with renewal terms that can extend the lease term from generally one New leased assets obtained in exchange for new operating lease liabilities during the three months ended March 31, 2022 were immaterial. Prior to March 31, 2022, the Company signed a lease extension for one of the buildings in Queretaro, Mexico. This extension led to the Company recognizing an additional ROU asset and related liability of $0.4 million. Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification March 31, 2022 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,757 Liabilities Current Operating Other accrued liabilities $ 1,736 Non-current Operating Other liabilities 8,661 Total lease liabilities $ 10,397 Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Three Months Ended March 31, 2022 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 669 Maturities of the Company’s lease liabilities as of March 31, 2022 are as follows: Lease Liability Maturities (dollars in thousands) 2022 (remainder) $ 1,846 2023 1,931 2024 1,840 2025 1,702 2026 1,472 Thereafter 4,225 Total lease payments 13,016 Less: interest 2,619 Present value of lease payments $ 10,397 As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Remaining lease term and discount rates are as follows: March 31, 2022 Weighted average remaining lease term (years) 6.8 Weighted average discount rate 6.5 % Lease costs included in the condensed consolidated statements of cash flows are as follows: Three Months Ended March 31, 2022 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 713

Retirement Plans

Retirement Plans	3 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Retirement Plans	Retirement PlansThe Company maintains a defined contribution plan covering certain full time salaried employees. Employees can make elective contributions to the plan. The Company contributes a match on 100% of an employee’s contribution up to the first 3% of each employee’s total compensation and 50% for the next 2% of each employee’s total compensation. In addition, the Company, at the discretion of the board of directors, may make additional contributions to the plan on behalf of the plan participants. The Company contributed $0.1 million for the three months ended March 31, 2022 and $0.1 million for the three months ended March 31, 2021.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Effective March 18, 2013, the Company is a party to a management agreement with a firm related to several stockholders. The agreement initially provided for annual management fees of $300 thousand and additional fees for assistance provided with acquisitions. Effective upon completion of the Company's initial public offering, the agreement was amended to reduce the annual management fee by an amount equal to the amount, if any, of annual cash retainers and equity awards received as compensation for service on the board of directors to any person who is a related person of Taglich Private Equity, LLC or Taglich Brothers, Inc (“Taglich”). The Company incurred management fees of $56 thousand for the three months ended March 31, 2021, however, the Forbearance Agreement suspended any further management fee payments until the expiration of the Forbearance Period. The management agreement had an initial term of five years, expiring on March 18, 2020, and renews automatically annually for additional one year terms. The current term expires on March 18, 2023. The agreement also will terminate on the date that the Taglich Founding Investors or Taglich Equity Investors, each as defined, no longer also collectively own 50% of the equity securities owned by either of them on March 18, 2013. Beginning in February 2021, the Company began utilizing the services of Engauge Workforce Solutions LLC (“Engauge”), a manufacturing and distribution staffing agency. Ms. Kim Korth, a member of the Company’s Board of Directors, is also the Managing Director of Engauge. In March 2021, the Company entered into an agreement with Engauge for its services. The agreement is for an initial term of 12 months and will continue on a month-to-month basis after the initial term. The Company may terminate the agreement, without penalty, following the initial term with 60 days written notice. The Company has incurred fees for Engauge’s services for the three months ended March 31, 2022 of $350 thousand.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value MeasurementsFinancial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variable and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap. The Company assess goodwill for impairment on at least an annual basis, and more frequently whenever events or changes in circumstances indicate a potential impairment. The goodwill impairment analysis is based on Level 3 inputs, including forecasted EBITDA margins and future cash flows.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed by dividing the net income by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed giving effect to all potentially weighted average dilutive shares including stock options and warrants. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share: Three Months Ended March 31, 2022 2021 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (569) $ (1,069) Denominator: Weighted average shares outstanding, basic 11,733,147 9,779,147 Dilutive effect of stock-based awards — — Weighted average share outstanding, diluted 11,733,147 9,779,147 Basic loss per share $ (0.05) $ (0.11) Diluted loss per share $ (0.05) $ (0.11) The effect of certain common stock equivalents were excluded from the computation of weighted average diluted shares outstanding for the three months ended March 31, 2022 and March 31, 2021, as inclusion would have resulted in anti-dilution. A summary of these anti-dilutive common stock equivalents is provided in the table below: Three Months Ended March 31, 2022 2021 Number of options 833,084 726,500 Exercise price of options $2.08 - $12.50 $2.36 - $12.58 Warrants (1) 156,320 Exercise price of warrants $3.12 _________________________________

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	ContingenciesThe Company is engaged from time to time in legal matters and proceedings arising out of its normal course of business. The Company establishes a liability related to its legal proceedings and claims when it has determined that it is probable that the Company has incurred a liability and the related amount can be reasonably estimated. If the Company determines that an obligation is reasonably possible, the Company will, if material, disclose the nature of the loss contingency and the estimated range of possible loss, or include a statement that no estimate of loss can be made. While uncertainties are inherent in the final outcome of such matters, the Company believes that there are no pending proceedings in which the Company is currently involved that will have a material effect on its financial position, results of operations or cash flow.

Nature of Business and Basis _2

Nature of Business and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Going Concern The Company’s condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2020 and March 31, 2021, the Company was in violation of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). The Company entered into a forbearance agreement, dated April 9, 2021, which allowed the Company to be able to borrow on its revolving line of credit, subject to the terms and conditions to making a revolving credit advance, including availability, and the lenders agreed, subject to the terms of the forbearance agreement, as amended, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. As of September 30, 2021, the Company was also in violation of the required Minimum Consolidated EBITDA covenant (as amended by the Second Amendment to the Forbearance Agreement dated September 21, 2021). On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement with respect to the Amended and Restated Credit Agreement, as amended. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment included a new covenant that began on December 15, 2021, which is tested weekly on a rolling basis and requires that the Company’s actual cumulative total cash disbursements for the period being tested not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required Minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment to the Forbearance Agreement agreed to waive the Minimum Liquidity covenant violation. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement The defaults, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement, totaling $47.0 million, has been classified as current as of March 31, 2022. The Company does not have sufficient cash and cash equivalents on hand or available liquidity to repay such debt or meet its obligations as they become due through twelve months from date of issuance of these condensed consolidated financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, the Company is discussing with its bank lenders entering into an amendment and waiver to cure the covenant defaults. There is not any assurance that the lenders will waive such non compliance or agree to an amendment to the current provisions. Even if the lenders were to agree to waive the failures to comply as of December 31, 2020, March 31, 2021, and September 30, 2021, there cannot be any assurance that, at any future date at which compliance is measured, we will be able to comply with the covenants contained in the forbearance agreement, as amended, given the industry-wide and other challenges that we face, as described elsewhere herein, or that our lenders would waive a default if that were to occur. Furthermore, there can be no assurance that the Company will be able to enter into an amendment or waiver with the lenders or if it enters into an amendment, what the terms, restrictions, and covenants of the amendment will contain. These plans have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
New Accounting Pronouncements	In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform (Topic 848). The amendments in this ASU clarify that certain option expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected.
Revenue Recognition	Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances
Fair Value Measurement	Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variable and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap. The Company assess goodwill for impairment on at least an annual basis, and more frequently whenever events or changes in circumstances indicate a potential impairment. The goodwill impairment analysis is based on Level 3 inputs, including forecasted EBITDA margins and future cash flows.

Nature of Business and Basis _3

Nature of Business and Basis of Presentation (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedules of Concentration of Risk	The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended March 31, 2022 2021 General Motors Company 9 % 7 % Yanfeng Automotive Interiors 10 % 7 % Stellantis N.V. 8 % 6 % Ford Motor Company 5 % 5 % Three Months Ended March 31, 2022 2021 Mexico 25 % 23 % Canada 9 % 10 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 26 % 24 % Canada 9 % 10 %

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents the Company's net sales disaggregated by major sales channel: Three Months Ended March 31, 2022 2021 (dollars in thousands) Net Sales Transportation $ 31,449 $ 31,244 Appliance 3,124 3,135 Other 739 419 Total $ 35,312 $ 34,798

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consist of the following: March 31, 2022 December 31, 2021 (dollars in thousands) Raw materials $ 9,472 $ 9,242 Work in progress 1,195 990 Finished goods 2,810 3,538 Total inventory $ 13,477 $ 13,770

Property, Plant, and Equipmen_2

Property, Plant, and Equipment, Net (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant, and equipment, net consists of the following: March 31, 2022 December 31, 2021 Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 7,630 7,630 23 – 40 Shop equipment 26,108 26,049 7 – 10 Leasehold improvements 1,283 1,283 3 – 10 Office equipment 3,048 3,047 3 – 7 Mobile equipment 50 50 3 Construction in progress 1,724 1,554 Total cost 40,381 40,151 Less: Accumulated depreciation 18,400 17,584 Net property, plant, and equipment, net $ 21,981 $ 22,567

Long-term Debt (Tables)

Long-term Debt (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	The Company’s long-term debt consists of the following: March 31, 2022 December 31, 2021 (dollars in thousands) US Term Loan, payable to lenders in quarterly installments of $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the US Term Loan is presented net of a debt discount of $113 thousand from costs paid to or on behalf of the lenders. $ 19,607 $ 20,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the CA Term Loan is presented net of a debt discount of $49 thousand from costs paid to or on behalf of the lenders. 7,082 7,437 Capital expenditure line payable to lenders in quarterly installments of 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. 1,024 1,064 Total debt excluding Revolver $ 27,713 $ 28,884
Schedule of Maturities of Long-Term Debt	Accordingly, all debt subject to the Credit Agreement has been classified as current as of March 31, 2022: Future Maturities (dollars in thousands) 2022 $ 47,426 Total 47,426 Discounts (162) Debt issuance costs (215) Total debt, net $ 47,049

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options and Stock Appreciation Rights Award Activity	A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2021 846,731 $ 4.00 7.6 $ — Granted — $ — 0 $ — Exercised — $ — 0 $ — Forfeited or expired 13,647 $ 4.51 0 $ — Outstanding at March 31, 2022 833,084 $ 4.00 7.4 $ — Vested and exercisable at March 31, 2022 390,129 $ 4.81 6.4 $ — ————————————

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Balance Sheet and Weighted-Average Lease Information	Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification March 31, 2022 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,757 Liabilities Current Operating Other accrued liabilities $ 1,736 Non-current Operating Other liabilities 8,661 Total lease liabilities $ 10,397 March 31, 2022 Weighted average remaining lease term (years) 6.8 Weighted average discount rate 6.5 %
Lease Cost Information	Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Three Months Ended March 31, 2022 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 669 Lease costs included in the condensed consolidated statements of cash flows are as follows: Three Months Ended March 31, 2022 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 713
Lease Maturity	Maturities of the Company’s lease liabilities as of March 31, 2022 are as follows: Lease Liability Maturities (dollars in thousands) 2022 (remainder) $ 1,846 2023 1,931 2024 1,840 2025 1,702 2026 1,472 Thereafter 4,225 Total lease payments 13,016 Less: interest 2,619 Present value of lease payments $ 10,397

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share: Three Months Ended March 31, 2022 2021 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (569) $ (1,069) Denominator: Weighted average shares outstanding, basic 11,733,147 9,779,147 Dilutive effect of stock-based awards — — Weighted average share outstanding, diluted 11,733,147 9,779,147 Basic loss per share $ (0.05) $ (0.11) Diluted loss per share $ (0.05) $ (0.11)
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share	A summary of these anti-dilutive common stock equivalents is provided in the table below: Three Months Ended March 31, 2022 2021 Number of options 833,084 726,500 Exercise price of options $2.08 - $12.50 $2.36 - $12.58 Warrants (1) 156,320 Exercise price of warrants $3.12 _________________________________

Nature of Business and Basis _4

Nature of Business and Basis of Presentation - Additional Information (Details)	Dec. 09, 2021USD ($)	Mar. 31, 2022USD ($)segment	Dec. 31, 2021USD ($)	Dec. 08, 2021USD ($)	Sep. 21, 2021USD ($)	Sep. 20, 2021USD ($)
Concentration Risk [Line Items]
Number of reportable segments | segment		1
Revolver, current maturities		$ 19,336,000	$ 19,541,000
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring August 2022
Concentration Risk [Line Items]
Concentration risk (percentage)		29.00%
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring February 2023
Concentration Risk [Line Items]
Concentration risk (percentage)		15.00%
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | United States
Concentration Risk [Line Items]
Concentration risk (percentage)		49.00%
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Mexico
Concentration Risk [Line Items]
Concentration risk (percentage)		48.00%
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Canada
Concentration Risk [Line Items]
Concentration risk (percentage)		3.00%
Revolving credit facility | Line of Credit
Concentration Risk [Line Items]
Maximum borrowing capacity	$ 25,000,000			$ 27,000,000	$ 27,000,000	$ 30,000,000
Forbearance Agreement | Line of Credit
Concentration Risk [Line Items]
Total cash disbursements	15.00%
Credit agreement
Concentration Risk [Line Items]
Revolver, current maturities		$ 47,000,000

Nature of Business and Basis _5

Nature of Business and Basis of Presentation - Customers' Net Sales as a Percentage of Total Net Sales (Details) - Sales Revenue, Net - Customer Concentration Risk	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
General Motors Company
Product Information [Line Items]
Concentration risk (percentage)	9.00%	7.00%
Yanfeng Automotive Interiors
Product Information [Line Items]
Concentration risk (percentage)	10.00%	7.00%
Stellantis N.V.
Product Information [Line Items]
Concentration risk (percentage)	8.00%	6.00%
Ford Motor Company
Product Information [Line Items]
Concentration risk (percentage)	5.00%	5.00%

Nature of Business and Basis _6

Nature of Business and Basis of Presentation - Production in Foreign Markets (Details) - Geographic Concentration Risk	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Mexico | Cost of Goods and Service Benchmark
Product Information [Line Items]
Concentration risk (percentage)	25.00%	23.00%
Mexico | Sales Revenue, Net
Product Information [Line Items]
Concentration risk (percentage)	26.00%	24.00%
Canada | Cost of Goods and Service Benchmark
Product Information [Line Items]
Concentration risk (percentage)	9.00%	10.00%
Canada | Sales Revenue, Net
Product Information [Line Items]
Concentration risk (percentage)	9.00%	10.00%

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Total sales	$ 35,312	$ 34,798
Transportation
Disaggregation of Revenue [Line Items]
Total sales	31,449	31,244
Appliance
Disaggregation of Revenue [Line Items]
Total sales	3,124	3,135
Other
Disaggregation of Revenue [Line Items]
Total sales	$ 739	$ 419

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 9,472	$ 9,242
Work in progress	1,195	990
Finished goods	2,810	3,538
Total inventory	$ 13,477	$ 13,770

Inventory - Additional Informat

Inventory - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Inventory [Line Items]
Allowance for obsolete inventory	$ 1,400	$ 1,200
Inventory, net	13,477	13,770
Mexico
Inventory [Line Items]
Inventory, net	3,700	4,000
Canada
Inventory [Line Items]
Inventory, net	$ 1,200	$ 1,100

Property, Plant, and Equipmen_3

Property, Plant, and Equipment, Net - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total cost	$ 40,381	$ 40,151
Less: Accumulated depreciation	18,400	17,584
Net property, plant, and equipment, net	21,981	22,567
Land
Property, Plant and Equipment [Line Items]
Total cost	538	538
Buildings
Property, Plant and Equipment [Line Items]
Total cost	$ 7,630	7,630
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	23 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	40 years
Shop equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 26,108	26,049
Shop equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	7 years
Shop equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	10 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total cost	$ 1,283	1,283
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	3 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	10 years
Office equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 3,048	3,047
Office equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	3 years
Office equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life – Years	7 years
Mobile equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 50	50
Depreciable Life – Years	3 years
Construction in progress
Property, Plant and Equipment [Line Items]
Total cost	$ 1,724	$ 1,554

Property, Plant, and Equipmen_4

Property, Plant, and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 800	$ 700
Property, plant, and equipment, net	21,981		$ 22,567
Mexico
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	3,500		3,500
Canada
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	$ 400		$ 400

Long-term Debt - Schedule of Lo

Long-term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Debt discount	$ 162	$ 200
Outstanding principal amount	$ 27,713	$ 28,884
Line of Credit | New US Term Loan | Secured Debt
Debt Instrument [Line Items]
Effective interest rate	5.50%	5.50%
Debt discount	$ 113
Outstanding principal amount	19,607	$ 20,383
Line of Credit | New US Term Loan | Secured Debt | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 800
Line of Credit | CA term loan | Secured Debt
Debt Instrument [Line Items]
Effective interest rate	5.50%	5.50%
Debt discount	$ 49
Outstanding principal amount	7,082	$ 7,437
Line of Credit | CA term loan | Secured Debt | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 400
Line of Credit | Capital expenditure line
Debt Instrument [Line Items]
Effective interest rate	5.50%	5.50%
Outstanding principal amount	$ 1,024	$ 1,064
Line of Credit | Capital expenditure line | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Percent of principal payment	12.50%

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Details) - USD ($)	Mar. 31, 2022	Dec. 09, 2021	Nov. 08, 2018	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 08, 2021	Sep. 21, 2021	Sep. 20, 2021
Debt Instrument [Line Items]
Outstanding principal amount	$ 27,713,000			$ 27,713,000		$ 28,884,000
Debt issuance cost	200,000			200,000		200,000
Unamortized discount	$ 162,000			162,000		200,000
Amortization expense of debt issuance costs				$ 100,000	$ 100,000
Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Minimum debt service coverage ratio	1.20			1.20
Amended and Restated Credit Agreement | Fiscal Quarter Ending September 30, 2020
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio	3.75			3.75
Debt instrument, covenant, multiplier				400.00%
Amended and Restated Credit Agreement | Fiscal Quarter Ending December 31, 2020
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio	3.50			3.50
Debt instrument, covenant, multiplier				200.00%
Amended and Restated Credit Agreement | Fiscal Quarter Ending March 31, 2021
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio	3.25			3.25
Debt instrument, covenant, multiplier				133.30%
Amended and Restated Credit Agreement | Fiscal Quarter Ending June 30, 2021
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio	3.25			3.25
Amended and Restated Credit Agreement | Fiscal Quarter Thereafter
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio	3			3
Forbearance Agreement | Trailing 12 Months
Debt Instrument [Line Items]
Limit to the excess above projected total cash disbursements (percent)	15.00%			15.00%
Forbearance Agreement | Line of Credit
Debt Instrument [Line Items]
Total cash disbursements		15.00%
Line of Credit | Amended and Restated Credit Agreement | Secured Debt
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 73,000,000
Line of Credit | Amended and Restated Credit Agreement | Secured Debt | Minimum | Base Rate | PPP under CARES Act
Debt Instrument [Line Items]
Basis spread on variable rate			2.00%
Line of Credit | Amended and Restated Credit Agreement | Secured Debt | Minimum | LIBOR | PPP under CARES Act
Debt Instrument [Line Items]
Basis spread on variable rate			1.00%
Line of Credit | Amended and Restated Credit Agreement | US Borrower and CA Borrower
Debt Instrument [Line Items]
Debt instrument, term			5 years
Debt instrument, term to fund capital expenditures			2 years
Line of Credit | Amended and Restated Credit Agreement | US Borrower and CA Borrower | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 30,000,000
Line of Credit | US Term loan | US Borrower and CA Borrower | Secured Debt
Debt Instrument [Line Items]
Maximum increase to principal amount			26,000,000
Line of Credit | CA term loan | Secured Debt
Debt Instrument [Line Items]
Outstanding principal amount	$ 7,082,000			$ 7,082,000		$ 7,437,000
Effective interest rate	5.50%			5.50%		5.50%
Unamortized discount	$ 49,000			$ 49,000
Line of Credit | CA term loan | US Borrower and CA Borrower | Secured Debt
Debt Instrument [Line Items]
Outstanding principal amount			$ 12,000,000
Line of Credit | Credit agreement | Secured Debt | Minimum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate			1.75%
Line of Credit | Credit agreement | Secured Debt | Minimum | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			2.75%
Line of Credit | Credit agreement | Secured Debt | Maximum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate			3.25%
Line of Credit | Credit agreement | Secured Debt | Maximum | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			4.25%
Line of Credit | First Amendment To Forbearance Agreement | Secured Debt | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate	4.50%		4.25%
Line of Credit | Forbearance Agreement | Secured Debt
Debt Instrument [Line Items]
Paid-in-kind percentage	0.50%			0.50%
Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 25,000,000					$ 27,000,000	$ 27,000,000	$ 30,000,000
Revolving credit facility | New Revolver | Line of Credit
Debt Instrument [Line Items]
Line of credit	$ 19,600,000			$ 19,600,000
Effective interest rate	5.50%			5.50%
Remaining borrowing capacity	$ 5,200,000			$ 5,200,000
Capital expenditure line | Amended and Restated Credit Agreement | US Borrower and CA Borrower | November 8, 2018 Through November 8, 2019
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 2,500,000
Capital expenditure line | Amended and Restated Credit Agreement | US Borrower and CA Borrower | November 9, 2019 Through November 8, 2020
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 5,000,000
Letter of credit | New Revolver | Line of Credit
Debt Instrument [Line Items]
Letters of credit outstanding, amount	$ 100,000			$ 100,000

Long-term Debt - Schedule of Re

Long-term Debt - Schedule of Repayment of Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
2022	$ 47,426
Total	47,426
Discounts	(162)	$ (200)
Debt issuance costs	(215)
Total debt, net	$ 47,049

Derivative Financial Instrume_2

Derivative Financial Instruments (Details) - Interest Rate Swap - Not Designated as Hedging Instrument - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Nov. 30, 2018
Derivatives, Fair Value [Line Items]
Fixed interest rate				3.075%
Notional amount				$ 5,000,000
Derivative net liability	$ 200,000		$ 600,000
Interest Expense
Derivatives, Fair Value [Line Items]
Monthly settlement payments (receipts)	$ 100,000	$ 100,000
Derivative Instrument, Periodic Payment, Installment Periods Through June Twenty Eight Two Thousand Nineteen
Derivatives, Fair Value [Line Items]
Notional amount				17,500,000
Quarterly increase in notional amount				400,000
Derivative Instrument, Periodic Payment, Installment Periods Until September Thirty Two Thousand Twenty
Derivatives, Fair Value [Line Items]
Notional amount				17,500,000
Quarterly decrease in notional amount				200,000
Derivative Instrument, Periodic Payment, Installment Periods Until November Eighth Twenty Twenty Three
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount				600,000
Derivative Instrument, Periodic Payment, Installment Periods Until December 31, 2021
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount				$ 400,000

Stock Incentive Plans - Additio

Stock Incentive Plans - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 29, 2013	Jul. 31, 2020	Jun. 30, 2016	Jan. 04, 2015
Selling, General and Administrative Expenses
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	$ 41	$ 27
Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Unrecognized compensation cost	$ 577
Compensation cost, weighted average period	3 years 7 months 6 days
The 2013 Stock Incentive Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares reserved for future issuance (in shares)			495,000
The 2013 Stock Incentive Plan | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares available for grant (in shares)			495,000
Expiration period			10 years
2014 Omnibus Performance Award Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares authorized (in shares)				700,000	450,000	250,000

Stock Incentive Plans - Schedul

Stock Incentive Plans - Schedule of Stock Options and Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Number of Shares
Outstanding at end of period (in shares)	833,084
Aggregate Intrinsic Value
Share price (in dollars per share)	$ 1.90	$ 1.96
The Plan and the 2014 Plan
Number of Shares
Outstanding at beginning of period (in shares)	846,731
Granted (in shares)	0
Exercised (in shares)	0
Forfeited or expired (in shares)	13,647
Outstanding at end of period (in shares)	833,084	846,731
Vested and exercisable (in shares)	390,129
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 4
Granted (in dollars per share)	0
Exercised (in dollars per share)	0
Forfeited or expired (in dollars per share)	4.51
Outstanding at end of period (in dollars per share)	4	$ 4
Vested and exercisable (in dollars per share)	$ 4.81
Weighted Average Remaining Contractual Term (in years)
Outstanding weighted average remaining contractual term	7 years 4 months 24 days	7 years 7 months 6 days
Granted	0 years
Exercised	0 years
Forfeited or expired	0 years
Vested and exercisable	6 years 4 months 24 days
Aggregate Intrinsic Value
Outstanding, beginning of period (in shares)		0
Forfeited or expired (in shares)	0
Outstanding, end of period (in shares)	$ 0
Vested and exercisable at end of period (in shares)	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ (165)	$ 442
Actual effective rate (percent)	22.00%

Leases - Additional Information

Leases - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)option_to_renew	Dec. 31, 2021USD ($)
Lessee, Lease, Description [Line Items]
Operating lease, right-of-use asset	$ 9,757	$ 9,776
Operating lease liability	$ 10,397
Lessee, Operating Leases, Number Of Renewal Options | option_to_renew	1
Buildings
Lessee, Lease, Description [Line Items]
Operating lease, right-of-use asset	$ 400
Operating lease liability	$ 400
Minimum
Lessee, Lease, Description [Line Items]
Renewal term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal term	5 years

Leases - Balance Sheet Informat

Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Right-of-Use-Assets
Operating leases	$ 9,757	$ 9,776
Liabilities
Operating lease, liability, current	$ 1,736
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities
Operating lease, liability, non-current	$ 8,661
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities
Total lease liabilities	$ 10,397

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Leases [Abstract]
Cost of sales, selling expenses and general and administrative expense	$ 669

Leases - Schedule of Lease Liab

Leases - Schedule of Lease Liabilities Maturity (Details) $ in Thousands	Mar. 31, 2022USD ($)
Leases [Abstract]
2021 (remainder)	$ 1,846
2023	1,931
2024	1,840
2025	1,702
2026	1,472
Thereafter	4,225
Total lease payments	13,016
Less: interest	2,619
Present value of lease payments	$ 10,397

Leases - Weighted-Average Lease

Leases - Weighted-Average Lease Information (Details)	Mar. 31, 2022
Leases [Abstract]
Weighted average remaining lease term (years)	6 years 9 months 18 days
Weighted average discount rate	6.50%

Leases - Cash Outflow Informati

Leases - Cash Outflow Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Leases [Abstract]
Operating cash outflows from operating leases	$ 713

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Employer contribution amount	$ 0.1	$ 0.1
Defined contribution plan, initial contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent	100.00%
Employer matching contribution, percent of employees gross pay	3.00%
Defined contribution plan, additional contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent	50.00%
Employer matching contribution, percent of employees gross pay	2.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	Mar. 18, 2013	Mar. 31, 2022	Mar. 31, 2021
Affiliated Entity | Management Agreement
Related Party Transaction [Line Items]
Annual management fees	$ 300
Expenses from agreement			$ 56
Management agreement, term	5 years
Additional renewal period term	1 year
Equity ownership needed to terminate agreement	50.00%
Engauge Workforce Solutions LLC ("Engauge")
Related Party Transaction [Line Items]
Expenses from agreement		$ 350
Agreement term			12 months
Written notice term			60 days

Earnings Per Share - Numerator

Earnings Per Share - Numerator and Denominator of Basic and Diluted Loss per Share Reconciliation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Net income (loss)	$ (569)	$ (1,069)
Denominator:
Weighted average shares outstanding, basic (in shares)	11,733,147	9,779,147
Dilutive effect of stock-based awards (in shares)	0	0
Weighted average shares outstanding, diluted (in shares)	11,733,147	9,779,147
Earnings Per Share, Basic and Diluted [Abstract]
Basic loss per share (in dollars per share)	$ (0.05)	$ (0.11)
Diluted loss per share (in dollars per share)	$ (0.05)	$ (0.11)

Earnings Per Share - Anti-Dilut

Earnings Per Share - Anti-Dilutive Common Stock Equivalents Summary (Details) - $ / shares	1 Months Ended	3 Months Ended
	Sep. 30, 2021	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of options (in shares)		833,084	726,500
Exercise price of options lower limit (in dollars per share)		$ 2.08	$ 2.36
Exercise price of options upper limit (in dollars per share)		$ 12.50	$ 12.58
Warrants (in shares)		156,320
Exercise price of warrants lower limit (in dollars per share)		$ 3.12
Warrants for Underwriters
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS (in shares)	156,320